Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionAsset Dedication, LLC
Latest Disclosed Ownership12,515 shares
Latest Disclosed Value $ 1,744,248
Asset Dedication, LLC reports 6.82% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 29, 2026 - Asset Dedication, LLC filed a 13F-HR form disclosing ownership of 12,515 shares of Gilead Sciences, Inc. (CH:GILD) valued at $1,744,248 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 13,431 shares of Gilead Sciences, Inc.. This represents a change in shares of -6.82% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-29 2026-03-31 13F GILEAD SCIENCES COM 375558103 12,515 -916 -6.82 1,744 5.83 0.1222
2026-01-26 2025-12-31 13F GILEAD SCIENCES COM 375558103 13,431 -2,277 -14.50 1,648 -5.45 0.1082
2025-11-20 2025-09-30 13F GILEAD SCIENCES COM 375558103 15,708 2,188 16.18 1,744 16.36 0.1171
2025-08-19 2025-06-30 13F GILEAD SCIENCES COM 375558103 13,520 882 6.98 1,499 5.79 0.1088
2025-05-01 2025-03-31 13F GILEAD SCIENCES COM 375558103 12,638 6,217 96.82 1,416 138.79 0.1149
2025-01-23 2024-12-31 13F GILEAD SCIENCES COM 375558103 6,421 1,940 43.29 593 58.13 0.0467
2024-10-15 2024-09-30 13F GILEAD SCIENCES COM 375558103 4,481 314 7.54 376 31.58 0.0253
2024-08-06 2024-06-30 13F GILEAD SCIENCES COM 375558103 4,167 -1,710 -29.10 286 0.0198
2024-04-16 2024-03-31 13F Gilead Sciences Equities 375558103 5,877 -877 -12.98 0 0.0322
2024-02-08 2023-12-31 13F Gilead Sciences Equities 375558103 6,754 813 13.68 1 0.0443
2023-11-13 2023-09-30 13F Gilead Sciences Equities 375558103 5,941 -73 -1.21 0 0.0383
2023-08-22 2023-06-30 13F Gilead Sciences Equities 375558103 6,014 284 4.96 0 0.0396
2023-04-24 2023-03-31 13F Gilead Sciences Equities 375558103 5,730 296 5.45 0 0.0436
2023-01-19 2022-12-31 13F Gilead Sciences Equities 375558103 5,434 579 11.93 0 -100.00 0.0472
2022-10-27 2022-09-30 13F Gilead Sciences Equities 375558103 4,855 4,855 301 0.0331
2022-07-18 2022-06-30 13F Gilead Sciences Equities 375558103 0 -2,683 -100.00 0 -100.00
2022-04-21 2022-03-31 13F Gilead Sciences Equities 375558103 2,683 -5,323 -66.49 160 -72.46 0.0178
2022-01-21 2021-12-31 13F Gilead Sciences Equities 375558103 8,006 -590 -6.86 581 -3.01 0.0700
2021-10-18 2021-09-30 13F Gilead Sciences Equities 375558103 8,596 1,527 21.60 599 23.25 0.0789
2021-07-21 2021-06-30 13F Gilead Sciences Equities 375558103 7,069 3,865 120.63 486 137.07 0.0724
2021-05-03 2021-03-31 13F Gilead Sciences Equities 375558103 3,204 210 7.01 205 17.14 0.0463
2021-01-28 2020-12-31 13F Gilead Sciences Equities 375558103 2,994 796 36.21 175 25.90 0.0349
2020-10-20 2020-09-30 13F Gilead Sciences Equities 375558103 2,198 -6,277 -74.06 139 -78.68 0.0307
2020-08-24 2020-06-30 13F Gilead Sciences Equities 375558103 8,475 1,103 14.96 652 17.90 0.1776
2020-05-05 2020-03-31 13F Gilead Sciences Equities 375558103 7,372 1,391 23.26 553 42.16 0.1645
2020-01-31 2019-12-31 13F Gilead Sciences Equities 375558103 5,981 -2,539 -29.80 389 -28.10 0.1099
2019-10-17 2019-09-30 13F Gilead Sciences Equities 375558103 8,520 289 3.51 541 -1.99 0.1799
2019-07-23 2019-06-30 13F Gilead Sciences Equities 375558103 8,231 1,394 20.39 552 25.45 0.1781
2019-04-19 2019-03-31 13F Gilead Sciences Equities 375558103 6,837 373 5.77 440 8.64 0.1531
2019-02-12 2018-12-31 13F Gilead Sciences Equities 375558103 6,464 -606 -8.57 405 -24.72 0.1662
2018-10-26 2018-09-30 13F Gilead Sciences Equities 375558103 7,070 440 6.64 538 13.03 0.2022
2018-08-13 2018-06-30 13F Gilead Sciences Equities 375558103 6,630 81 1.24 476 -2.86 0.1626
2018-04-19 2018-03-31 13F Gilead Sciences Equities 375558103 6,549 801 13.94 490 17.79 0.2430
2018-01-17 2017-12-31 13F Gilead Sciences Equities 375558103 5,748 3,721 183.57 416 155.21 0.1675
2017-10-18 2017-09-30 13F Gilead Sciences Equities 375558103 2,027 -327 -13.89 163 -2.98 0.0786
2017-07-17 2017-06-30 13F Gilead Sciences Equities 375558103 2,354 -1,140 -32.63 168 -29.71 0.0845
2017-04-20 2017-03-31 13F Gilead Sciences Equities 375558103 3,494 -132 -3.64 239 -9.13 0.1291
2017-01-17 2016-12-31 13F Gilead Sciences Equities 375558103 3,626 -2,706 -42.74 263 -48.83 0.1525
2016-11-18 2016-09-30 13F/A-2 Gilead Sciences Equities 375558103 6,332 -158 -2.43 514 -6.88 0.3246
2016-10-19 2016-09-30 13F Gilead Sciences Equities 375558103 7,066 646
2016-11-18 2016-06-30 13F/A-1 Gilead Sciences Equities 375558103 6,490 -576 -8.15 552 -14.95 0.3836
2016-07-14 2016-06-30 13F Gilead Sciences Equities 375558103 7,066 646
2016-04-27 2016-03-31 13F Gilead Sciences Equities 375558103 7,066 241 3.53 649 -6.08 0.4772
2016-02-16 2015-12-31 13F Gilead Sciences EQUITIES 375558103 6,825 6,825 691 0.4535
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.